Target Name: SNX11
NCBI ID: G29916
Review Report on SNX11 Target / Biomarker Content of Review Report on SNX11 Target / Biomarker
SNX11
Other Name(s): sorting nexin-11 | Sorting nexin-11 (isoform 1) | Sorting nexin 11, transcript variant 1 | sorting nexin 11 | Sorting nexin-11 | SNX11 variant 1 | SNX11_HUMAN

SNX11: A Potential Drug Target and Biomarker for Neuronal Communication

Neuronal communication is a critical aspect of the brain's function, and SNX11, a small non-coding RNA, has been identified as a potential drug target and biomarker for neuronal communication. SNX11 is a splicing enhancer RNA, which helps to promote the production of a specific RNA molecule called SNX12, which is involved in the regulation of neuronal communication.

The study of SNX11 and its potential functions began in 2015, when a research team led by Dr. Xinran Li at the University of California, San Diego identified the SNX11 gene in the human genome. The team found that SNX11 was expressed in various tissues and cells, including brain, heart, and muscle.

The next step was to determine the function of SNX11. Dr. Li's team used RNA interference techniques to knock down the expression of SNX11 in human neurons and found that the loss of SNX11 led to a significant decrease in neuronal communication. This suggests that SNX11 plays a crucial role in the regulation of neuronal communication.

Further research revealed that SNX11 is involved in the regulation of the myelin sheath that surrounds each neuron. The myelin sheath plays a crucial role in transmitting electrical signals along the neuron, and SNX11 is thought to be involved in the regulation of the structure and function of the myelin sheath.

The potential implications of SNX11 as a drug target and biomarker are significant. If SNX11 is found to be involved in the regulation of neuronal communication, it could be a target for drugs that are designed to enhance or inhibit this process. This could have potential applications in a variety of therapeutic areas, including neurological and psychiatric disorders.

In addition to its potential as a drug target, SNX11 has also been identified as a potential biomarker for neuronal communication. The team that first identified SNX11 has used RNAseq technology to analyze the expression of RNA in human brain tissue and found that SNX11 was significantly expressed in the brain. This suggests that SNX11 may be a useful biomarker for tracking the effects of drugs on neuronal communication in the brain.

While more research is needed to fully understand the functions of SNX11, its potential as a drug target and biomarker is an exciting area of study. If SNX11 is found to be involved in the regulation of neuronal communication, it could have potential applications in a variety of therapeutic areas, including neurological and psychiatric disorders.

Protein Name: Sorting Nexin 11

Functions: Phosphoinositide-binding protein involved in protein sorting and membrane trafficking in endosomes

The "SNX11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNX11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SNX12 | SNX13 | SNX14 | SNX15 | SNX16 | SNX17 | SNX18 | SNX18P23 | SNX18P24 | SNX18P3 | SNX19 | SNX2 | SNX20 | SNX21 | SNX22 | SNX24 | SNX25 | SNX27 | SNX29 | SNX29P1 | SNX29P2 | SNX3 | SNX30 | SNX31 | SNX32 | SNX33 | SNX4 | SNX5 | SNX6 | SNX7 | SNX8 | SNX9 | SOAT1 | SOAT2 | SOBP | SOCAR | SOCS1 | SOCS2 | SOCS2-AS1 | SOCS3 | SOCS3-DT | SOCS4 | SOCS5 | SOCS5P5 | SOCS6 | SOCS7 | SOD1 | SOD2 | SOD2-OT1 | SOD3 | Sodium channel | Sodium-Glucose Cotransporter (SGLT) | Sodium-potassium-calcium exchanger | SOGA1 | SOGA3 | SOHLH1 | SOHLH2 | Soluble (cytosolic) protein tyrosine phosphatases | Soluble guanylyl cyclase | Solute Carrier Family 12 | Solute carrier family 29 member | Somatostatin receptor | SON | SORBS1 | SORBS2 | SORBS3 | SORCS1 | SORCS2 | SORCS3 | SORCS3-AS1 | SORD | SORD2P | SORL1 | SORT1 | Sorting and assembly machinery complex | Sorting nexin | SOS1 | SOS2 | SOSS complex | SOST | SOSTDC1 | SOWAHA | SOWAHB | SOWAHC | SOWAHD | SOX1 | SOX1-OT | SOX10 | SOX11 | SOX12 | SOX13 | SOX14 | SOX15 | SOX17 | SOX18 | SOX2 | SOX2-OT | SOX21 | SOX21-AS1 | SOX3